v3.26.1
Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Segmented Assets (Details) - USD ($)
Mar. 31, 2026
Dec. 31, 2025
BioBusiness Segment [Member]    
Schedule of Segmented Assets [Line Items]    
Cash & Cash Equivalents $ 921,284 $ 1,492,054
Restricted Cash
Short Term Investments 1,500,000 2,000,000
Prepaid Expenses 2,647,579 2,374,189
Digital assets, at fair value
Other Assets 228,371 239,021
Total Assets 5,297,234 6,105,264
Digital Asset Segment [Member]    
Schedule of Segmented Assets [Line Items]    
Cash & Cash Equivalents 55,704 144,600
Restricted Cash
Short Term Investments
Prepaid Expenses
Digital assets, at fair value 127,815,173 149,885,371
Other Assets
Total Assets 127,870,877 150,029,971
Corporate Segment [Member]    
Schedule of Segmented Assets [Line Items]    
Cash & Cash Equivalents 2,546
Restricted Cash 8,000,000 8,000,000
Short Term Investments
Prepaid Expenses
Digital assets, at fair value
Other Assets 48,500 48,500
Total Assets 8,051,046 8,048,500
Consolidated [Member]    
Schedule of Segmented Assets [Line Items]    
Cash & Cash Equivalents 979,534 1,636,654
Restricted Cash 8,000,000 8,000,000
Short Term Investments 1,500,000 2,000,000
Prepaid Expenses 2,647,579 2,374,189
Digital assets, at fair value 127,815,173 149,885,371
Other Assets 276,871 287,521
Total Assets $ 141,219,157 $ 164,183,736